ROIV Roivant Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: ROIV
Price (delayed)
$11.49
Market cap
$7.81B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.24
Enterprise value
$5.2B
Highlights
The company's gross margin rose by 3.1% QoQ
The company's quick ratio rose by 34% YoY but it fell by 10% QoQ
The net income has dropped by 104% year-on-year and by 47% since the previous quarter
The EPS has shrunk by 104% YoY and by 26% QoQ
Key stats
What are the main financial stats of ROIV
Market
Valuations
Earnings
Shares outstanding
679.81M
Market cap
$7.81B
Enterprise value
$5.2B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.75
Price to sales (P/S)
286.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
178.84
Revenue
$29.05M
Gross profit
$28.14M
Operating income
-$1B
Net income
-$171.98M
EBIT
-$123.81M
EBITDA
-$102.89M
Free cash flow
-$844.05M
Per share
Balance sheet
Liquidity
EPS
-$0.24
EPS diluted
-$0.24
Free cash flow per share
-$1.16
Book value per share
$6.57
Revenue per share
$0.04
TBVPS
$7.5
Total assets
$5.44B
Total liabilities
$249.74M
Debt
$100.17M
Equity
$4.69B
Working capital
$4.85B
Debt to equity
0.02
Current ratio
33.47
Quick ratio
32.71
Net debt/EBITDA
25.42
Margins
Efficiency
Dividend
EBITDA margin
-354.2%
Gross margin
96.9%
Net margin
-592%
Operating margin
-3,453.3%
Return on assets
-2.9%
Return on equity
-3.4%
Return on invested capital
-4.5%
Return on capital employed
-2.3%
Return on sales
-426.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ROIV stock price
How has the Roivant Sciences stock price performed over time
Intraday
-0.52%
1 week
1.59%
1 month
5.8%
1 year
5.9%
YTD
-2.87%
QTD
1.95%
Financial performance
How have Roivant Sciences's revenue and profit performed over time
Revenue
$29.05M
Gross profit
$28.14M
Operating income
-$1B
Net income
-$171.98M
Gross margin
96.9%
Net margin
-592%
ROIV's operating margin has dropped by 184% since the previous quarter and by 125% year-on-year
ROIV's operating income has dropped by 122% year-on-year and by 6% since the previous quarter
The net margin has dropped by 104% year-on-year
The net income has dropped by 104% year-on-year and by 47% since the previous quarter
Price vs fundamentals
How does ROIV's price correlate with its fundamentals
Growth
What is Roivant Sciences's growth rate over time
Valuation
What is Roivant Sciences stock price valuation
P/E
N/A
P/B
1.75
P/S
286.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
178.84
The EPS has shrunk by 104% YoY and by 26% QoQ
The stock's price to book (P/B) is 80% less than its 5-year quarterly average of 8.8 but 9% more than its last 4 quarters average of 1.6
ROIV's equity is down by 21% year-on-year and by 10% since the previous quarter
The stock's price to sales (P/S) is 106% more than its last 4 quarters average of 139.0 and 87% more than its 5-year quarterly average of 153.6
Roivant Sciences's revenue has shrunk by 63% QoQ and by 11% YoY
Efficiency
How efficient is Roivant Sciences business performance
The ROS has shrunk by 103% YoY
ROIV's return on assets has dropped by 103% year-on-year and by 61% since the previous quarter
The ROE has shrunk by 103% YoY and by 62% QoQ
The ROIC has plunged by 101% YoY but it has grown by 8% from the previous quarter
Dividends
What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ROIV.
Financial health
How did Roivant Sciences financials performed over time
ROIV's total liabilities has dropped by 68% year-on-year and by 2.6% since the previous quarter
The company's quick ratio rose by 34% YoY but it fell by 10% QoQ
The debt is 98% smaller than the equity
The debt to equity has surged by 100% year-on-year
The debt has surged by 86% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.